Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Apollo Endosurgery Inc (NQ: APEN )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Apollo Endosurgery Inc

< Previous 1 2 3 Next >
Apollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022
Via ACCESSWIRE
Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure
Via ACCESSWIRE
Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure
Publication of MERIT Study Follows FDA Market Authorization of Apollo ESG™ 
From Apollo Endosurgery, Inc.
Via AccessWire
Exposures Product Safety
Apollo Endosurgery to Report Second Quarter Results on August 2, 2022
Via ACCESSWIRE
Apollo Endosurgery to Report Second Quarter Results on August 2, 2022
AUSTIN, TX / ACCESSWIRE / July 21, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery's New Obesity Endoscopic Systems Receive FDA Nod
Via Benzinga
This Analyst Thinks Apollo Endosurgery's Valuation 'Does Not Assign Full Value' - Read Why
Via Benzinga
Apollo Endosurgery: Q1 Earnings Insights
Apollo Endosurgery (NASDAQ:APEN) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th. 
Via Benzinga
Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th. 
Via Benzinga
Earnings Scheduled For February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity
Systems Offer Effective, Minimally Invasive Treatment Options for Millions of Patients with Obesity (BMI 30-50 kg/m2) 
From Apollo Endosurgery, Inc.
Via AccessWire
Exposures Product Safety
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG and Apollo REVISE, New Endoscopic Systems for Patients with Obesity
Via ACN Newswire
Exposures Product Safety
Sharon O'Keefe Joins Apollo Endosurgery Board of Directors
Seasoned healthcare leader brings 30 years of hospital system and medical technology expertise 
From Apollo Endosurgery, Inc.
Via AccessWire
Digestive Disease Week 2022 Adds to the Growing Wave of Clinical Evidence Supporting Significant Opportunity for Apollo Endosurgery Products
AUSTIN, TX / ACCESSWIRE / May 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Products to Take Center Stage at Digestive Disease Week
AUSTIN, TX / ACCESSWIRE / May 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery, Inc. Reports 33% U.S. Revenue Growth in First Quarter 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery to Report First Quarter Results on May 3, 2022
AUSTIN, TX / ACCESSWIRE / April 13, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (Nasdaq:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors
Veteran Brings 30 Years of Multinational Healthcare Leadership Experience AUSTIN, TX / ACCESSWIRE / April 4, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally... 
From Apollo Endosurgery, Inc.
Via AccessWire
68 Biggest Movers From Yesterday
Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to... 
Via Benzinga
Apollo Endosurgery to Participate in the Cowen Healthcare Conference
AUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery's Return On Capital Employed Insights
Apollo Endosurgery (NASDAQ:APEN) brought in sales totaling $16.17 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 56.3%, resulting in a... 
Via Benzinga
Recap: Apollo Endosurgery Q4 Earnings
Apollo Endosurgery (NASDAQ:APEN) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:01 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
Apollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021
- Increased adoption across all product lines in both U.S. and international - Grew fourth quarter 2021 revenue 26% AUSTIN, TX / ACCESSWIRE / February 22, 2022 / Apollo Endosurgery, Inc. ("Apollo")... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery to Report Fourth Quarter and Full Year Results on February 22, 2022
AUSTIN, TX / ACCESSWIRE / February 10, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access
Veteran Leader Brings 25 Years of Global Medical Device Experience AUSTIN, TX / ACCESSWIRE / January 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020
Fourth quarter 2021 revenue grew 25% over 2020 AUSTIN, TX / ACCESSWIRE / January 10, 2022 / Apollo Endosurgery, Inc. ("Apollo" or the "Company") (NASDAQ:APEN), a global leader in less invasive medical... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLC
- $35 million funded at close to refinance existing debt, extend maturity and lower interest expense - Additional borrowing capacity provides minimally dilutive growth capital and strategic flexibility... 
From Apollo Endosurgery, Inc.
Via AccessWire
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.